Compensatory sweating after restricting or lowering the level of sympathectomy: a systematic review and meta-analysis

Abstract

OBJECTIVE:

To compare compensatory sweating after lowering or restricting the level of sympathectomy.

METHOD:

A systematic review and meta-analysis were conducted of all randomized controlled trials published in English that compared compensatory sweating after lowering or restricting the level of sympathectomy. The Cochrane collaboration tool was used to assess the risk of bias, and the Mantel-Haenszel odds ratio method was used for the meta-analysis.

RESULTS:

A total of 11 randomized controlled trials were included, including a total of 1079 patients. Five of the randomized controlled trials studied restricting the level of sympathectomy, and the remaining six studied lowering the level of sympathectomy.

CONCLUSIONS:

The compiled randomized controlled trial results published so far in the literature do not support the claims that lowering or restricting the level of sympathetic ablation results in less compensatory sweating.

Sympathectomy; Compensatory sweating; Meta-analysis

INTRODUCTION

Endoscopic thoracic sympathectomy (ETS) is known to be a highly efficient method for treating palmar hyperhidrosis (PH). The success rate of ETS is greater than 95% in most series (¹). However, controversy remains regarding the optimum level and extent of sympathectomy. The main source of the debate is the presence of compensatory sweating (CS), which substantially influences the quality of life after these operations (²). The pathophysiology of CS remains unknown. Chou and Lin reported that lowering the level of sympathectomy could reduce CS (³,⁴), and Licht and Yazbek suggested that lowering the level of sympathectomy could reduce severe CS (⁵,⁶). However, a thorough review of 246 articles has shown that the literature from 1999 to 2006 does not support this claim (⁷).

To date, there is only one systematic review and meta-analysis published in English examining compensatory sweating after the treatment of PH (⁸). The review only included studies in which sympathectomy was used to treat PH, and the papers included not only randomized controlled trials (RCTs) but also clinical trials because of the limited number of RCTs. ETS is used to treat not only PH but also facial blushing, facial hyperhidrosis, and axillary hyperhidrosis, among other conditions. Recently, several RCT studies on treating facial blushing and axillary hyperhidrosis have been published (⁹,¹⁰).

Therefore, we are the first group to conduct a meta-analysis of RCTs on ETS to assess whether lowering or restricting the level of sympathectomy can reduce compensatory sweating.

METHODS

Study selection

A systematic literature search with predefined search terms of “hyperhidrosis” or “facial blushing” and “sympathectomy” or “sympathicotomy” was conducted in MEDLINE (from 1960), EMBASE (all years), Cochrane Library (issue 2, 2013), and Web of Science (all years). The search was conducted in July 2013 and was limited to RCTs published in English. All of the full texts or abstracts and their citations were scanned and reviewed.

Inclusion criteria

The inclusion criteria were RCTs comparing CS and severe CS after endoscopic thoracic sympathectomy.

Exclusion criteria

Studies were excluded from the analysis if they did not meet the inclusion criteria or if the corresponding author was not able to provide data from the published results. Abstracts of RCTs were excluded if the fundoplication circumference, surgical technique, methodological quality, and risk of bias could not be assessed.

Data extraction

The titles and abstracts of all retrieved records followed by the full text of the articles were examined independently by two authors (Cai SW and Zhang JH) according to the Quality of Reporting of Meta-analyses guidelines (¹¹-¹³). The corresponding author for each included publication was contacted if information was missing or unclear. If no response was received within 1 month, we used the available data for the analyses.

Risk of bias assessment

The risk of bias was assessed for all of the articles using both Cochrane Collaboration's tool for assessing the risk of bias (¹⁴) and the Jadad scoring system (¹⁵). Cochrane Collaboration's tool evaluates random sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other sources of bias. The Jadad scoring system assesses randomization, double blinding and withdrawals and dropouts, with a total score of 5. Any discrepancies were resolved by discussion among all of the authors.

Statistical analysis

Meta-analyses of the RCTs and observational studies were performed separately in all analyses using Review Manager 5.2. A separate meta-analysis was performed for bariatric surgery and non-bariatric surgery across both subgroups. In all analyses, the outcomes of surgical site infection were calculated as odds ratios (ORs) with 95% confidence intervals (CIs). For pooled estimates, the Mantel-Haenszel [chi]² method was used. Statistical heterogeneity for the pooled ORs was calculated as I² with a Z-statistic test for the overall effect. A fixed effects model was applied for meta-analysis of the RCTs when I² <40%. A random effects model was used for meta-analysis of the observational studies irrespective of the I² value due to considerable clinical heterogeneity in the surgical procedures and study designs (¹⁶).

RESULTS

Characteristics of the pooled RCTs

A total of 2719 studies were searched; 11 studies fulfilled the inclusion criteria and were included in this study. The meta-analysis included 11 RCT studies with a total of 1079 patients (585 in the experimental groups and 519 in the control groups), and 25 patients were enrolled in both an experimental group and a control group because they had undergone unilateral T2 and T3 ablation followed by contralateral ablation at level T2 only. Five of the RCTs studied restricting the level of sympathectomy (¹⁷-²¹), and six studied lowering the level of sympathectomy (²²-²⁶) (Table 1). Two of the studies did not report the exact number of severe CS patients (¹⁹,²⁰), and we obtained the unpublished results by e-mail. In both cases, the studies had no severe CS patients.

Table 1
Description of the Included Studies.

Authors	Year	Country	Sympathectomy		Follow-up	n		EG		CG
			EG	CG	(month)	EG	CG	CS	Severe CS	CS	Severe CS
Baumgartner	2011	USA	T3	T2	More than 12	60	61	37	1	43	1
Inan	2008	Turkey	T2-4,T2-3	T2-4	35.3±15.6	60	20	13	absence	3	absence
Ishy	2011	Brazil	T4-5	T3-4	12	20	20	15	1	20	1
Katara	2007	Singapore	T2	T2-3	2-65	25	25	20	0	20	0
Li	2008	China	T3	T2-4	1-12	117	115	25	4	33	11
Licht	2012	Denmark	T2	T2-3	More than 12	42	51	40	0	46	0
Liu	2009	China	T4	T3	17.8±7.9	73	68	39	0	48	0
Mahdy	2008	Egypt	T3-4,T4-5	T2-3	13±8	40	20	11	5	12	7
Munia	2008	Brazil	T4-5	T3-5	12	33	31	14	0	29	0
Yang	2007	China	T4	T3	13.8±6.2	85	78	38	0	55	0
Yazbek	2009	Brazil	T3-4	T2-3	20	30	30	29	4	28	13

• EG, Experiment group; CG, Control group.

One study allocated patients into four groups; we designated group 3 in that study as the control group and the other three groups as experimental groups according to the operation location (¹⁸). One study divided patients into three groups; we renamed the R2-3 group as the control group and the other groups as experimental groups based on the level of operation (²⁵). Table 2 presents the results of the risk of bias assessment for the included studies.

Table 2
Risk of Bias.

Author	Cochrane Risk of Bias Criteria							Jadad score
	Random sequence generation	Allocation concealment	Blinding of participants and personnel	Blinding of outcome assessment	Incomplete outcome data	Selective reporting	Other sources of bias
Baumgartner F.J.	Low	Unclear	High	High	Low	Low	Low	2
Inan K.	Unclear	Unclear	High	High	Low	Low	Low	2
Ishy A	Low	Unclear	High	High	Low	Low	Low	2
Katara A.N.	Low	Low	High	High	Low	Low	Low	3
Li X	Low	Low	High	High	Low	Low	Low	3
Licht PB	Low	Low	Low	Low	High	Low	Low	4
Liu YG	Low	Unclear	High	High	Low	Low	Low	2
Mahdy T	Low	Low	High	High	Low	Low	Low	3
Munia MA	Unclear	Unclear	High	High	Low	Low	Low	2
Yang J	Low	Unclear	High	High	Low	Low	Low	2
Yazbek G	Low	Unclear	High	High	Low	Low	Low	2

• The level of bias was determined as follows: “Low” indicates a low risk of bias;”Unclear” indicates an uncertain risk of bias; and “High” indicates a high risk of bias.

Quality assessment

In general, the overall methodological study quality was good (Table 2). Most studies applied randomization and concealed the patient allocation information. However, most studies were not double blinded because this design is difficult to accomplish in the perioperative period.

Publication bias

There were inadequate numbers of RCTs to assess publication bias. Funnel plots were drawn for each outcome. Based on the graphical examination, no asymmetry of the funnel plots was found; therefore, no publication bias was present (data not shown).

Restricting or lowering the level of sympathectomy

The test for heterogeneity showed that statistical heterogeneity was detected between the two groups in terms of CS after the operation (I² = 54%; p = 0.02), and a random effects model was used. CS differed between the two groups (OR: 0.52; 95% CI: 0.32 to 0.84; p = 0.008), as shown in Figure 1. The test for heterogeneity showed that statistical heterogeneity was not detected between the two groups regarding severe CS after the operation (I² = 0%; p = 0.76), and a fixed effects model was used. Subgroup analysis revealed that the two groups were significantly different regarding severe CS after the operation (OR: 0.31; 95% CI: 0.16 to 0.61; p = 0.006) (data not shown).

Figure 1
CS after restricting or lowering the level of sympathectomy. CI, confidence interval; CS, compensatory sweating.

Restricting the level of sympathectomy

The test for heterogeneity showed that statistical heterogeneity was detected between the two groups in terms of CS after the operation (I² = 71%; p = 0.007), and a random effects model was used. CS did not differ between groups (OR: 0.66; 95% CI: 0.23 to 1.88; p = 0.44), as shown in Figure 2. Subgroup analysis revealed that the two groups were not significantly different in terms of severe CS after the operation (OR: 0.33; 95% CI: 0.10 to 1.08; p = 0.007) (data not shown).

Figure 2
CS after restricting the level of sympathectomy. CI, confidence interval; CS, compensatory sweating.

Lowering the level of sympathectomy

Statistical heterogeneity was not detected between the two groups (I² = 15%, p = 0.32), and a fixed effects model was used. Lowering the level of sympathectomy significantly reduced CS compared with that of the control group (OR: 0.43; 95% CI: 0.30 to 0.61; p<0.00001), as shown in Figure 3. Subgroup analysis revealed that lowering the level of sympathectomy significantly reduced the severe CS compared with the control group (OR: 0.30; 95% CI: 0.13 to 0.67; p = 0.004), and statistical heterogeneity was not detected (I² = 0%; p = 0.61) (data not shown).

Figure 3
CS after lowering the level of sympathectomy. CI, confidence interval; CS, compensatory sweating.

Preserving the T2 level in the sympathectomy

Statistical heterogeneity was not detected between the two groups (I² = 29%; p = 0.23), and a fixed effects model was used. Preserving the T2 level during sympathectomy reduced CS compared with that of the control group (OR: 0.51; 95% CI: 0.36 to 0.73; p = 0.0002), as shown in Figure 4. Subgroup analysis revealed that preserving T2 in the sympathectomy significantly reduced the severe CS compared with that of the control group (OR: 0.29; 95% CI: 0.14 to 0.58; p = 0.0005), and statistical heterogeneity was not detected (I² = 0%; p = 0.61) (data not shown).

Figure 4
CS after preserving T2 in sympathectomy. CI, confidence interval; CS, compensatory sweating.

DISCUSSION

The results of this meta-analysis show that restricting or lowering the level of sympathectomy can decrease CS after surgery. However, statistical heterogeneity was found. To explore the heterogeneity, we conducted subgroup analyses on restricting the level of sympathectomy and lowering the level of sympathectomy. The results indicated that the statistical heterogeneity mainly originated in the subgroup in which the level of sympathectomy was restricted.

Subgroup analysis indicated that lowering the level of sympathectomy can reduce CS and severe CS after surgery but that restricting the level of sympathectomy does not reduce CS and severe CS. These findings differ from those of the meta-analysis conducted by Deng et al and published in 2009 (⁸). That meta-analysis demonstrated that single ganglia sympathectomy could reduce the total CS and severe CS compared with multiple ganglia blocking.

Our results showed that lowering the level of sympathectomy can reduce CS and severe CS after surgery, and this finding implies that the T2 ganglia may be very important for CS after ETS. The T2 ganglion is considered important for sympathetic innervation of the upper extremities. Some investigators have suggested that preservation of the T2 ganglion may decrease the severity of CS (³,²⁷). Based on feedback mechanisms, Chou and his colleagues believe that T2 sympathectomy stops the main negative feedback sympathetic signals and that T2 sympathectomy therefore causes more severe CS than does T3 or T4 sympathectomy (³). To explore this phenomenon, we divided the data into two groups: an experimental group in which T2 was not reserved and a control group in which T2 was reserved. The meta-analysis results showed that preserving T2 increases CS.

We were unable to determine the optimal approach for sympathectomy. Multiple sympathectomy techniques have been described in the literature, including those in our analysis: T2-4, T2-3, T2, T3-5, T3-4, T3, T4-5 and T4. Excluding T2-4, T2-3 and T2 sympathectomy based on our finding that the group in which T2 was preserved showed increased CS, only four studies analyzed T3-5, T3-4, T3, T4-5 and T4 sympathectomy. We were therefore unable to assess the superiority of T3-5, T3-4, T3, T4-5 and T4 sympathectomy.

This is the first systematic review and meta-analysis of RCTs investigating ETS to assess whether lowering or restricting the level of sympathectomy can reduce compensatory sweating. The methodological approach in this systematic review has its strengths and limitations. One strength is the inclusion of RCTs.

The limitations of this study are the inclusion of trials of low methodological and surgical quality and the presence of significant heterogeneity in the results. The Oxford Centre for Evidence Based Medicine guidelines show that although systematic reviews of RCTs are considered to be the highest level of evidence, this determination relies on the absence of significant methodological, clinical and statistical heterogeneity. If a systematic review/meta-analysis has significant heterogeneity, then the maximum recommended grade that can be allocated is the lowest level (D) (²⁸). A lack of standardized definitions may be responsible for heterogeneity in the results. There are many nomenclature systems used to describe the exact level of cautery or chain and ganglia clipping used in ETS procedures; this variety of systems complicates any attempt to compare the results of various studies. The degrees of CS are also analyzed according to many different criteria.

Another limitation is the low sample size. There are only 11 included studies, and the number of included studies was insufficient to perform some of the preplanned subgroup and meta-regression analyses.

In our study, the heterogeneity in the meta-analysis in terms of restricting the level of sympathectomy to reduce CS was significant. In other words, the results pertaining to restricting the level of sympathectomy to reduce CS are underpowered.

In summary, the compiled RCT results published so far in the literature do not support the claims that lowering or restricting the level of sympathetic ablation results in less CS.

ACKNOWLEDGMENTS

This study was supported by the “985” project of Sun Yat-sen University (No. 82000-31101301) to Dr. Junhang Zhang.

REFERENCES

• ¹
  Gossot D, Galetta D, Pascal A, Debrosse D, Caliandro R, Girard P, et al. Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg. 2003;75(4):1075-9, http://dx.doi.org/10.1016/S0003-4975(02)04657-X.
  » http://dx.doi.org/10.1016/S0003-4975(02)04657-X
• ²
  Chang YT, Li HP, Lee JY, Lin PJ, Lin CC, Kao EL, et al. Treatment of palmar hyperhidrosis: T(4) level compared with T(3) and T(2). Ann Surg. 2007;246(2):330-6, http://dx.doi.org/10.1097/SLA.0b013e3180caa466.
  » http://dx.doi.org/10.1097/SLA.0b013e3180caa466
• ³
  Chou SH, Kao EL, Lin CC, Chang YT, Huang MF. The importance of classification in sympathetic surgery and a proposed mechanism for compensatory hyperhidrosis: experience with 464 cases. Surg Endosc. 2006;20(11):1749-53, http://dx.doi.org/10.1007/s00464-005-0829-7.
  » http://dx.doi.org/10.1007/s00464-005-0829-7
• ⁴
  Lin CC, Telaranta T. Lin-Telaranta classification: the importance of different procedures for different indications in sympathetic surgery. Ann Chir Gynaecol. 2001;90(3):161-6.
• ⁵
  Licht PB, Pilegaard HK. Severity of compensatory sweating after thoracoscopic sympathectomy. Ann Thorac Surg. 2004;78(2):427-31, http://dx.doi.org/10.1016/j.athoracsur.2004.02.087.
  » http://dx.doi.org/10.1016/j.athoracsur.2004.02.087
• ⁶
  Yazbek G, Wolosker N, de Compos JR, Kauffman P, Ishy A, Puech-Leão P. Plamar hyperhidrosis—which is the best level of denervation using video-assisted thoracoscopic sympathecotmy: T2 or T3 ganglion? J Vasc Surg. 2005;42(2):281-5, http://dx.doi.org/10.1016/j.jvs.2005.03.041.
  » http://dx.doi.org/10.1016/j.jvs.2005.03.041
• ⁷
  Kopelman D, Hashmonai M. The Correlation Between the Method of Sympathetic Ablation for Palmar Hyperhidrosis and the occurrence of Compensatory Hyperhidrosis: a review. World J Surg. 2008;32(11):2343-56.
• ⁸
  Deng B, Tan QY, Jiang YG, Zhao YP, Zhou JH, Ma Z, et al. Optimization of sympathectomy to treat palmar hyperhidrosis: the systematic review and meta-analysis of studies published during the past decade. Surg Endosc. 2011;25(6):1893-901, http://dx.doi.org/10.1007/s00464-010-1482-3.
  » http://dx.doi.org/10.1007/s00464-010-1482-3
• ⁹
  Licht PB, Pilegaard HK, Ladegaard L. Sympathicotomy for isolated facial blushing: a randomized clinical trial. Ann Thorac Surg. 2012;94(2):401-5, http://dx.doi.org/10.1016/j.athoracsur.2012.03.076.
  » http://dx.doi.org/10.1016/j.athoracsur.2012.03.076
• ¹⁰
  Munia MA, Wolosker N, Kaufmann P, de Campos JR, Puech-Leão P. Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis. Clinics. 2008;63(6):771-4.
• ¹¹
  Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896-900.
• ¹²
  Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-12.
• ¹³
  Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet. 2001;357(9270):1728, http://dx.doi.org/10.1016/S0140-6736(00)04934-5.
  » http://dx.doi.org/10.1016/S0140-6736(00)04934-5
• ¹⁴
  Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. [updatedMarch2011].(Acessed July 28, 2013 at:http://handbook.cochrane.org)
  » http://handbook.cochrane.org
• ¹⁵
  Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12, http://dx.doi.org/10.1016/0197-2456(95)00134-4.
  » http://dx.doi.org/10.1016/0197-2456(95)00134-4
• ¹⁶
  Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Part 3: fixed-effect versus random-effect models. In: Borenstein M, Hedges LV, Higgins JPT, et al., eds. Introduction to Meta-analysis. Hoboken, NJ: Wiley. pp. 61-102(2009).
• ¹⁷
  Katara AN, Domino JP, Cheah WK, So JB, Ning C, Lomanto D. Comparing T2 and T2-T3 ablation in thoracoscopic sympathectomy for palmar hyperhidrosis: a randomized control trial. Surg Endosc. 2007;21(10):1768-71, http://dx.doi.org/10.1007/s00464-007-9241-9.
  » http://dx.doi.org/10.1007/s00464-007-9241-9
• ¹⁸
  Inan K, Goksel OS, Ucak A, Temizkan V, Karaca K, Ugur M, et al. Thoracic endoscopic surgery for hyperhidrosis: comparison of different techniques. Thorac Cardiovasc Surg. 2008;56(4):210-3, http://dx.doi.org/10.1055/s-2007-989327.
  » http://dx.doi.org/10.1055/s-2007-989327
• ¹⁹
  Munia MA, Wolosker N, Kaufmann P, de Campos JR, Puech-Leao P. Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis. Clinics. 63(6):771-4.
• ²⁰
  Licht PB, Pilegaard HK, Ladegaard L. Sympathicotomy for isolated facial blushing: a randomized clinical trial. Ann Thorac Surg. 2012;94(2):401-5, http://dx.doi.org/10.1016/j.athoracsur.2012.03.076.
  » http://dx.doi.org/10.1016/j.athoracsur.2012.03.076
• ²¹
  Li X, Tu YR, Lin M, Lai FC, Chen JF, Dai ZJ. Endoscopic thoracic sympathectomy for palmar hyperhidrosis: a randomized control trial comparing T3 and T2-4 ablation. Ann ThoracSurg. 2008;85(5):1747-51, http://dx.doi.org/10.1016/j.athoracsur.2008.01.060.
  » http://dx.doi.org/10.1016/j.athoracsur.2008.01.060
• ²²
  Ishy A, de Campos JR, Wolosker N, Kauffman P, Tedde ML, Chiavoni CR, et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg. 2011;12(4):545-8, http://dx.doi.org/10.1510/icvts.2010.252015.
  » http://dx.doi.org/10.1510/icvts.2010.252015
• ²³
  Baumgartner FJ, Reyes M, Sarkisyan GG, Iglesias A, Reyes E. Thoracoscopic sympathicotomy for disabling palmar hyperhidrosis: a prospective randomized comparison between two levels. Ann Thorac Surg. 2011;92(6):2015-9, http://dx.doi.org/10.1016/j.athoracsur.2011.07.083.
  » http://dx.doi.org/10.1016/j.athoracsur.2011.07.083
• ²⁴
  Yazbek G, Wolosker N, Kauffman P, Campos JR, Puech-Leao P, Jatene FB. Twenty months of evolution following sympathectomy on patients with palmar hyperhidrosis: sympathectomy at the T3 level is better than at the T2 level. Clinics. 2009;64(8):743-9, http://dx.doi.org/10.1590/S1807-59322009000800006.
  » http://dx.doi.org/10.1590/S1807-59322009000800006
• ²⁵
  Mahdy T, Youssef T, Elmonem HA, Omar W, Elateef AA. T4 sympathectomy for palmar hyperhidrosis: looking for the right operation. Surgery. 2008;143(6):784-9, http://dx.doi.org/10.1016/j.surg.2008.01.007.
  » http://dx.doi.org/10.1016/j.surg.2008.01.007
• ²⁶
  Liu Y, Yang J, Liu J, Yang F, Jiang G, Li J, et al. Surgical treatment of primary palmar hyperhidrosis: a prospective randomized study comparing T3 and T4 sympathicotomy. Eur J Cardiothorac Surg. 2009;35(3):398-402, http://dx.doi.org/10.1016/j.ejcts.2008.10.048.
  » http://dx.doi.org/10.1016/j.ejcts.2008.10.048
• ²⁷
  Schmidt J, Bechara FG, Altmeyer P, Zirngibl H. Endoscopic thoracic sympathectomy for severe hyperhidrosis: impact of restrictive denervation on compensatory sweating. Ann ThoracSurg. 2006;81(3):1048-55, http://dx.doi.org/10.1016/j.athoracsur.2005.09.046.
  » http://dx.doi.org/10.1016/j.athoracsur.2005.09.046
• ²⁸
  Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine. (Accessed 20 October, 2013 at www.cebm.net/levels of evidence).
  » www.cebm.net/levels

Publication Dates

• Publication in this collection
  Mar 2015

History

• Received
  3 Aug 2014
• Reviewed
  25 Nov 2014
• Accepted
  5 Jan 2015